Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells

International Journal of Cancer

Volumn 88, Issue 4, 2000, Pages 566-574

  Alper, Özge ^a   De Santis, Marta L ^a,d   Stromberg, Kurt ^b   Hacker, Neville F ^c   Cho Chung, Yoon S ^a   Salomon, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c ROYAL HOSPITAL FOR WOMEN   (Australia)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; NEU DIFFERENTIATION FACTOR; TYROSINE; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ALPHA CATENIN; ANIMALS; BETA CATENIN; CADHERINS; CELL ADHESION; CELL DIVISION; CYTOSKELETAL PROTEINS; DNA, ANTISENSE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033761255     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001115)88:4<566::AID-IJC8>3.0.CO;2-D     Document Type: Article

References (52)

1. Cadherin-catenin complex: Protein interactions and their implications for cadherin function
2. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors
3. Protein kinase A-RIα subunit-directed anti-sense inhibition of ovarian cancer cell growth: Crosstalk with tyrosine kinase signaling pathway
4. Human ovarian surface epithelium: Growth patterns and differentiation
5. Characterization of growth factors in human ovarian carcinomas
6. The occurrence of epidermal growth receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas
7. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness
8. Adherens junction proteins in tumor progression
9. Epidermal growth factor receptor (EGFR) anti-sense transfection reduces the expression of EGFR and suppresses the malignant phenotype of a human ovarian cancer cell line
10. Proteolytic processing of the adherens junctions components β-catenin and γ-catenin/plakoglobulin during apoptosis
11. Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells
12. The EGF receptor is an actin-binding protein
13. Over-expression of ERBB2 in human mammary epithelial cell signals inhibition of transcription of the E-cadherin gene
14. Control of adhesion-dependent cell survival by focal adhesion kinase
15. mRNA phenotyping of the major ligands and receptors of the EGFR supergene family in human ovarian epithelial cells
16. Expression of epidermal growth factor receptors on human Cervical, ovarian and vulval carcinomas
17. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor anti-sense RNA transcribed from the U6 promoter
18. Dynamics of cadherin-catenin complex formation: Novel protein interactions and pathways of complex assembly
19. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
20. Expression of E-cadherin in normal, benign and malignant tissues of female genital organs
21. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
22. Interaction of alpha-catenin
23. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance
24. Cancer statistics
25. c-erbB2 amplification and over-expression in human tumors
26. Increased E-cadherin expression in ovarian surface epithelium: An early step in metaplasia and dysplasia?
27. Clinical perspective cell-surface proteins for growth factors as cancer markers: Epidermal growth factor receptor and HER-2/neu protein
28. EGFR anti-sense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line
29. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells
30. Over-expression of RIIβ-regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RIIβ
31. An ovarian adenocarcinoma line derived from: SV40/E-cadherin-transfected normal human ovarian surface epithelium
32. ErbB receptor expression and growth response to heregulin β1 in five ovarian carcinoma cell lines
33. Establishment of the circumferential actin filament network is a prerequisite for localization of the cadherin-catenin complex in epithelial cells
34. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells
35. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line
36. E-cadherin mediated adhesion system in cancer cells
37. c-erbB growth-factor-receptor proteins in ovarian tumors
38. Biological effect of epidermal growth factor on in vitro growth of human tumors
39. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene
40. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
41. Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors
42. Enhanced E-cadherin expression in epidermal growth factor receptor expressing cells
43. Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis
44. Ecadherin expression in human epithelial ovarian cancer and normal ovary
45. Induction of tyrosine phosphorylation and association of β-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence
46. Morphogenetic roles of classic cadherins
47. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells
48. Changes in expression of differentiation markers between normal ovarian cells and derived tumors
49. ErbB2 exprossion increases the spectrum and potency of ligand-mediated signal transduction through ErbB4
50. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals
51. Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression
52. Cadherins